Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 09/28 | 09/30 | 2,000 sh | $513.45 | $1,026,900 | −2.9% |
Andrea R. LindellDirector | ChemedCHE | Open-market sale | 06/09 | 06/10 | 1,347 sh | $447.33 | $602,553.51 | −22.7% |
George J. Walsh IIIDirector | ChemedCHE | Open-market sale | 05/29 | 05/29 | 500 sh | $437.83 | $218,915 | −13.5% |
Patrick P. GraceDirector | ChemedCHE | Open-market sale | 05/08 | 05/08 | 60 sh | $425.78 | $25,546.8 | −1.8% |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 05/01 | 05/04 | 2,000 sh | $421.13 | $842,260 | −2.2% |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 03/27 | 03/30 | 1,500 sh | $369.37 | $554,055 | −1.6% |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 03/12 | 03/13 | 2,000 sh | $403.18 | $806,360 | −2.1% |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 25/11/24 | 25/11/25 | 2,000 sh | $437.55 | $875,100 | −2.1% |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 25/09/26 | 25/09/29 | 3,000 sh | $461.28 | $1,383,840 | −3.0% |
Patrick P. GraceDirector | ChemedCHE | Open-market sale | 25/09/09 | 25/09/10 | 150 sh | $463.39 | $69,508.5 | −4.2% |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 25/08/05 | 25/08/05 | 2,000 sh | $428.55 | $857,100 | −2.0% |
George J. Walsh IIIDirector | ChemedCHE | Open-market buy | 25/08/04 | 25/08/05 | 200 sh | $417.10 | $83,420 | +6.0% |
ChemedCHE | Open-market sale | 25/08/04 | 25/08/05 | 10,012 sh | $421.91 | $4,224,162.92 | −100.0% | |
ChemedCHE | Open-market sale | 25/05/16 | 25/05/19 | 1,500 sh | $577.99 | $866,985 | −9.3% | |
ChemedCHE | Open-market sale | 25/05/07 | 25/05/08 | 1,500 sh | $577.86 | $866,790 | −8.5% | |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 25/05/05 | 25/05/06 | 1,500 sh | $576.45 | $864,675 | −1.5% |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 25/03/31 | 25/04/01 | 1,000 sh | $615.33 | $615,330 | −1.0% |
Kevin J. McNamarapresident and CEO | ChemedCHE | Open-market sale | 25/03/06 | 25/03/07 | 2,000 sh | $593.67 | $1,187,340 | −1.9% |
ChemedCHE | Open-market sale | 25/03/03 | 25/03/03 | 1,326 sh | $592.25 | $785,323.5 | −7.0% | |
Brian C. JudkinsVP and Chief Legal Officer | ChemedCHE | Open-market buy | 24/12/30 | 24/12/30 | 145 sh | $519.50 | $75,327.5 | +9.5% |